MA43103B1 - Macrocyclic peptides against acetinobacter baumannii - Google Patents
Macrocyclic peptides against acetinobacter baumanniiInfo
- Publication number
- MA43103B1 MA43103B1 MA43103A MA43103A MA43103B1 MA 43103 B1 MA43103 B1 MA 43103B1 MA 43103 A MA43103 A MA 43103A MA 43103 A MA43103 A MA 43103A MA 43103 B1 MA43103 B1 MA 43103B1
- Authority
- MA
- Morocco
- Prior art keywords
- macrocyclic peptides
- peptides against
- baumannii
- acetinobacter
- formula
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000588626 Acinetobacter baumannii Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des composés représentés par la formule (i) dans laquelle , x 1 à x8 et r1 à r8 ont la signification indiquée dans la description, ainsi que des sels pharmaceutiquement acceptables de ceux-ci. La présente invention concerne également la fabrication des composés de formule (i), des compositions pharmaceutiques les comprenant et leur utilisation comme médicaments pour le traitement de maladies et d'infections causée par acinetobacter baumannii .The present invention relates to compounds represented by formula (i) in which, x 1 to x8 and r1 to r8 have the meanings given in the description, as well as pharmaceutically acceptable salts thereof. The present invention also relates to the manufacture of compounds of formula (i), pharmaceutical compositions comprising them and their use as medicaments for the treatment of diseases and infections caused by acinetobacter baumannii.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15191743 | 2015-10-27 | ||
| PCT/EP2016/075499 WO2017072062A1 (en) | 2015-10-27 | 2016-10-24 | Peptide macrocycles against acinetobacter baumannii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43103B1 true MA43103B1 (en) | 2020-08-31 |
Family
ID=54539821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA43103A MA43103B1 (en) | 2015-10-27 | 2016-10-24 | Macrocyclic peptides against acetinobacter baumannii |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR106511A1 (en) |
| BR (1) | BR112018008585A2 (en) |
| MA (1) | MA43103B1 (en) |
-
2016
- 2016-10-24 BR BR112018008585A patent/BR112018008585A2/en active Search and Examination
- 2016-10-24 MA MA43103A patent/MA43103B1/en unknown
- 2016-10-27 AR ARP160103280A patent/AR106511A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR106511A1 (en) | 2018-01-24 |
| BR112018008585A2 (en) | 2018-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA39995B1 (en) | Compounds for treating spinal muscular atrophy | |
| MX2022010520A (en) | Peptide macrocycles against acinetobacter baumannii. | |
| MA40111A1 (en) | Derivatives of tetrahydronaphthalene inhibiting mcl-1 protein | |
| MX379459B (en) | Bromodomain inhibitors | |
| BR112015022643A2 (en) | dihydropyrrolpyridinone inhibitors | |
| PH12016500024A1 (en) | Bromodomain inhibitor | |
| NZ708593A (en) | Novel pyrazole derivative | |
| UA111588C2 (en) | JAK INHIBITOR COMPOSITION FOR LOCAL APPLICATION | |
| BR112015022861A8 (en) | bromodomain inhibitors | |
| MA40225A (en) | SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS | |
| UA113538C2 (en) | FLUOROMETHYL-5,6-DIHYDRO-4H- $ 1,3] OXAZINES | |
| MA39165A1 (en) | Benzimidazole-proline derivatives for their use in the treatment of crepuscular state syndrome | |
| EA201591541A1 (en) | BETA SECRETASE INHIBITORS 1 (BACE 1) | |
| EA201590066A1 (en) | DIFTORGEXAHYDROCYCLOPENTAXOXASYNYLES AND DIFTORGEXAHYDROBENZOXASYNYLES AS BETA SECRETASE INHIBITORS | |
| MA43052B1 (en) | Human Plasma Kallikrein Inhibitors | |
| EA201492097A1 (en) | 5-AMINO [1,4] TIAZINS AS BETA SECRETASE INHIBITORS 1 | |
| JOP20190086A1 (en) | Naphthyridinone derivatives and their use in the treatment of arrhythmia | |
| EA201890532A1 (en) | NEW ANNELED BENZAMIDES | |
| EA201992090A1 (en) | Deuterated Imidazo [4,5-c] Quinolin-2-One Compounds and Their Use in Cancer Treatment | |
| TN2018000214A1 (en) | Alkyl dihydroquinoline sulfonamide compounds | |
| MX2019004375A (en) | Bromodomain inhibitors. | |
| MA39229A1 (en) | Pyrrolidines, terrahydrofurans and substituted cyclopentanes useful as orexin receptor antagonists | |
| MA38857B1 (en) | Derivatives of 1- (piperazin-1-yl) -2 - ([1,2,4] triazol-1-yl) -ethanone | |
| BR112015023078A2 (en) | pyrrolopyrimindine cdk9 kinase inhibitors | |
| MX2019004187A (en) | Bromodomain inhibitors. |